Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Findings from M. Buijs and co-researchers advance knowledge in breast cancer
April 7th, 2009
In this recent study, researchers in the United States conducted a study "To evaluate the anti-glycolytic effects of 3-BrPA on rats bearing RMT mammary tumors, by determining FDG uptake after intravenous administration of the therapeutic dose. Sixteen rats bearing RMT tumors were treated either with 15 mM 3-BrPA in 2.5 ml of PBS or with 2.5 ml of PBS." "After treatment, all rats received FDG and were sacrificed 1 h later. 3-BrPA treatment significantly decreased FDG uptake in tumors by 77% (p = 0.002). FDG uptake did not significantly decrease in normal tissues after treatment," wrote M. Buijs and colleagues. The researchers concluded: "Our study...
Source: Cancer Weekly (2009-04-07)
|
